Sfoglia per Autore
Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells
2011 C. Carlo-Stella, A.M. Gianni, A. Giacomini, C. Lavazza, S.L. Locatelli
PRECLINICAL RATIONALE FOR THE USE OF THE AKT INHIBITOR PERIFOSINE IN COMBINATION WITH THE MULTIKINASE INHIBITOR SORAFENIB IN HODGKIN LYMPHOMA
2012 S..L. Locatelli
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells
2013 C. Carlo-Stella, S.L. Locatelli, A. Giacomini, L. Cleris, E. Saba, M. Righi, A. Guidetti, A.M. Gianni
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34+ cells
2013 A. Giacomini, M. Righi, L. Cleris, S.L. Locatelli, S. Mitola, M.G. Daidone, A.M. Gianni, C. Carlo-Stella
Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies
2013 M. Marconi, B. Ascione, L. Ciarlo, R. Vona, T. Garofalo, M. Sorice, A.M. Gianni, S.L. Locatelli, C. Carlo-Stella, W. Malorni, P. Matarrese
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
2013 S.L. Locatelli, A. Giacomini, A. Guidetti, L. Cleris, R. Mortarini, A. Anichini, A. Gianni, C. Carlo Stella
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders
2014 M. Pierdominici, C. Barbati, M. Vomero, S.L. Locatelli, C. Carlo-Stella, E. Ortona, W. Malorni
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts
2014 S.L. Locatelli, L. Cleris, G. Stirparo, S. Tartari, E. Saba, M. Pierdominici, W. Malorni, A. Carbone, A. Anichini, C. Carlo-Stella
DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation
2014 P.L. Cattaneo, P. Kunderfranco, C. Greco, A. Guffanti, G. Stirparo, F. Rusconi, R. Rizzi, E. Di Pasquale, S. Locatelli, M. Latronico, C. Bearzi, R. Papait, G. Condorelli
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma
2018 V. Spina, A. Bruscaggin, A. Cuccaro, M. Martini, M. Di Trani, G. Forestieri, M. Manzoni, A. Condoluci, A. Arribas, L. Terzi-Di-Bergamo, S.L. Locatelli, E. Cupelli, L. Ceriani, A.A. Moccia, A. Stathis, L. Nassi, C. Deambrogi, F. Diop, F. Guidetti, A. Cocomazzi, S. Annunziata, V. Rufini, A. Giordano, A. Neri, R. Boldorini, B. Gerber, F. Bertoni, M. Ghielmini, G. Stüssi, A. Santoro, F. Cavalli, E. Zucca, L.M. Larocca, G. Gaidano, S. Hohaus, C. Carlo-Stella, D. Rossi
FGF trapping inhibits multiple myeloma growth through c-Myc degradation-induced mitochondrial oxidative stress
2020 R. Ronca, G.C. Ghedini, F. Maccarinelli, A. Sacco, S.L. Locatelli, E. Foglio, S. Taranto, E. Grillo, S. Matarazzo, R. Castelli, G. Paganini, V. Desantis, N. Cattane, A. Cattaneo, M. Mor, C. Carlo-Stella, A. Belotti, A. Roccaro, M. Presta, A. Giacomini
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile